Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1CNS 1

Conditions

Venous Thromboembolism 1Glioma 1Dyskinesias 1Chemotherapy-Induced Febrile Neutropenia 1

Interventions

apixaban 22Rivaroxaban 16Dalteparin 16Enoxaparin 11Heparin, Low-Molecular-Weight 10Tinzaparin 8Aspirin 8Fondaparinux 4Dabigatran 4edoxaban 3Warfarin 3Nadroparin 3bemiparin 2abelacimab 2Rosuvastatin Calcium 2Observation 2MAA868 2sotorasib 1ribociclib 1reviparin 1palbociclib 1isoquercitrin 1enoxaparin sodium 1certoparin 1calcium heparin 1betrixaban 1argatroban 1acarboxyprothrombin 1abemaciclib 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Venous Thromboembolism × Long-Term Synaptic Depression × Classical hematology × Clear all
NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Nanfang Hospital, Southern Medical University

Phase NA Unknown
320 enrolled
CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡